CEO, PSS Segment
Avg Cost/Share
$236.44
Shares
7,354
Total Value
$1,731,523.86
Owned After
78,590
CEO, PSS Segment
Avg Cost/Share
$150.53
Shares
21,367
Total Value
$3,216,374.51
Owned After
78,590
SEC Form 4
CEO, Pharmaceutical Segment
Avg Cost/Share
$106.31
Shares
36,642
Total Value
$3,895,411.02
Owned After
78,590
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| WEITZMAN DEBORAH | CAH | CEO, PSS Segment | Aug 18, 2026 | Sell | $236.44 | 7,354 | $1,731,523.86 | 78,590 | |
| WEITZMAN DEBORAH | CAH | CEO, PSS Segment | Aug 20, 2025 | Sell | $150.53 | 21,367 | $3,216,374.51 | 78,590 | |
| WEITZMAN DEBORAH | CAH | CEO, Pharmaceutical Segment | Nov 27, 2023 | Sell | $106.31 | 36,642 | $3,895,411.02 | 78,590 |